David E. Anderson
2022
In 2022, David E. Anderson earned a total compensation of $995.4K as Chief Scientific Officer at VBI Vaccines, a 45% decrease compared to previous year.
Compensation breakdown
| Bonus | $80,100 |
|---|---|
| Option Awards | $461,188 |
| Salary | $445,000 |
| Other | $9,150 |
| Total | $995,438 |
Anderson received $461.2K in option awards, accounting for 46% of the total pay in 2022.
Anderson also received $80.1K in bonus, $445K in salary and $9.2K in other compensation.
Rankings
In 2022, David E. Anderson's compensation ranked 3,029th out of 5,672 executives tracked by ExecPay. In other words, Anderson earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,029 out of 5,672 | 47th |
Division Manufacturing | 1,700 out of 3,081 | 45th |
Major group Chemicals And Allied Products | 798 out of 1,396 | 43rd |
Industry group Drugs | 744 out of 1,297 | 43rd |
Industry Pharmaceutical Preparations | 538 out of 940 | 43rd |
Source: SEC filing on May 1, 2023.
Anderson's colleagues
We found two more compensation records of executives who worked with David E. Anderson at VBI Vaccines in 2022.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019